Purpose: Although surgical resection offers patients with HCC the chance of a cure, the post-resection tumor recurrence rate is high, with reported cumulative 5-year tumor recurrence rates ranging from 40 to 70%. The objective of this study was to investigate risk factors for intrahepatic recurrence after resection of hepatocellular carcinoma, especially in patients with hepatitis B virus infection. Methods: Between January 1999 and December 2003, 59 patients in our Hospital with hepatitis B virus infection underwent liver resection for hepatocellular carcinoma. Clinical, biological, and histopathological characteristics of these patients were collected and tested for their prognostic significance using a Chi-square test and a Student's t-test. Time to recurrence and survival rate were analyzed by the Kaplan-Meier method. Results: Of the 59 patients who underwent liver resection, 24 (41%) experienced intrahepatic recurrence. The 1-, 3-, and 5-year overall survival rates of total enrolled patients were 83%, 63%, and 42%, respectively. The 1-, 3-, and 5-year overall survival rates after recurrence were 87%, 52%, and 20%, respectively. The risk factors for early recurrence were elevated serum aspartate aminotransferase (AST) level (p=0.044) and larger tumor size (p=0.049). For late recurrence, greater tumor size (p=0.039) was the only risk factor. Conclusion: Tumor size and serum aspartate aminotransferase are risk factors of intrahepatic recurrence after resection of HCC in patients with chronic hepatitis B virus infection. This finding indicates that patients who have these risk factors should be under more careful supervision and have more aggressive follow-up.
Introduction
Hepatocellular carcinoma is unique in that it largely occurs within an established background of chronic liver disease and cirrhosis, which are mostly attributed to hepatitis B virus (HBV) and hepatitis C virus (HCV), the main causal agents of chronic hepatitis. 1 In South Korea, where 5∼6% of the population are carriers of HBV, there are approximately 10,000 new hepatocellular carcinoma (HCC) cases each year, and the overall incidence rate of HCC is 46.5 cases per 100,000 population, making it the third most common cancer in Korea after stomach and lung cancers. 2 With treatment options of liver transplantation, radiofrequency ablation, transarterial chemoembolization (TACE), and radiation therapy, the optimal management of HCC remains controversial. In patients with anatomically resec- 
Survival rate
The mean follow up period was 40 months. The 1-, 3-, and 5-year overall survival rates of enrolled patients were 83%, 63%, and 42%, respectively. The 1-, 3-, and 5-year overall survival rates after recurrence were 87%, 52%, and 20%, respectively. Differences in survival rate between early, late, and non-recurrence groups were not quite statistically significant (p=0.056) (Fig. 1) .
Discussion
Although radical resection is the most effective treatment method for hepatocellular carcinoma, it has been reported that the long-term survival rate is low due to the high recurrence rate after hepatectomy and, according to these reports, 69∼75% of cases recur within 5 years and 78∼
92% of these are intrahepatic recurrence. [9] [10] [11] The recurrence of hepatocellular carcinoma is believed to be caused by intrahepatic metastasis through the hepatic portal vein and metachronous multicentric carcinogenesis in the remaining liver parenchyma. 7, 12 In addition, some studies have reported chronic active hepatitis and liver cirrhosis as the most important risk factors of multicentric carcinogenesis. 13, 14 According to these reports, the repeated inflammatory responses and hepatocellular necrosis in As mentioned above, an intrahepatic chronic inflammatory response is not only a causative factor of primary hepatoma, but also can be a major factor influencing its recurrence after hepatectomy. 15 Park and colleagues 5 reported that, of 904 patients with HCC in a hepatitis B virus-endemic area, 76.3% were positive for hepatitis B antigen, and 72.7.% showed the presence of cirrhosis.
Similarly, in our study, the preoperative level of serum AST in hepatoma patients with hepatitis B was a factor affecting recurrence after hepatectomy. This was statistically significant, particularly in the early recurrence group, and suggests that a severe inflammatory response in the liver is related to recurrence. Park et al. 21 reported that tumor size -hepatocellular carcinoma ≥5 cm diameter -is associated with postoperative early recurrence. When the tumor is large, there is a high possibility of microvascular invasion by hepatocellular carcinoma that is barely detectable on imaging, the grade of differentiation is low, and the disease is often multinodular, which is a factor related to recurrence.
Furthermore, many cases are accompanied by liver cirrhosis, which causes hepatic dysfunction and makes it difficult to secure a sufficiently large resection margin.
These factors are believed to be associated with the high recurrence rate after hepatectomy when the tumor is large. 22, 23 In our study, although the mean size of the mass was 44.9 mm for all of the surgical patients, it was 37.2 mm in the non-recurrence group and 51.9 mm in the early recurrence group and the difference between the two groups was statistically significant (p=0.049). Thus, the size of the mass is believed to affect both early recurrence and late recurrence.
We followed patients with hepatocellular carcinoma related to hepatitis B for an average of 40 months postoperatively, and did not see a statistically significant difference in the survival rate among the non-recurrence group, the early recurrence group, and the late recurrence group (p=0.056), although it just missed being significant.
In addition, no difference in the survival rate was observed between the non-recurrence group and the late recurrence group.
Summing up, as described in many previous reports on the postoperative survival rate of patients with hepatocellular carcinoma related to hepatitis B, early recurrence is considered an important factor related to the survival rate.
Conclusion
Our 
